These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 16794994

  • 1. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S.
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [Abstract] [Full Text] [Related]

  • 2. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ, Zuckerman IH, Lee E.
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [Abstract] [Full Text] [Related]

  • 3. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 4. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S, Jirapinyo M, Chaovisitsaree S, Wipatavit V, Bunyaviroch S, Kanluan B, Panyakhamlerd K, Jaisamrarn U, Taechakraichana N.
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [Abstract] [Full Text] [Related]

  • 5. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG.
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [Abstract] [Full Text] [Related]

  • 6. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M, Vallée MH, Plante M, Chiquette J, Gaudet M, Simard J.
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
    Barbaglia G, Macià F, Comas M, Sala M, del Mar Vernet M, Casamitjana M, Castells X.
    Menopause; 2009 Jan; 16(5):1061-4. PubMed ID: 19369903
    [Abstract] [Full Text] [Related]

  • 11. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.
    Menopause; 2006 Jan; 13(1):125-9. PubMed ID: 16607108
    [Abstract] [Full Text] [Related]

  • 12. Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years' National Cohort study.
    Kuo DJ, Lee YC, Huang WF.
    Maturitas; 2007 Nov 20; 58(3):259-68. PubMed ID: 17920215
    [Abstract] [Full Text] [Related]

  • 13. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.
    Pharmacoepidemiol Drug Saf; 2005 Oct 20; 14(10):685-95. PubMed ID: 15645517
    [Abstract] [Full Text] [Related]

  • 14. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.
    Maturitas; 2006 Sep 20; 55(2):103-15. PubMed ID: 16815651
    [Abstract] [Full Text] [Related]

  • 15. Changes in utilisation of hormone replacement therapy in Australia following publication of the findings of the Women's Health Initiative.
    Main P, Robinson M.
    Pharmacoepidemiol Drug Saf; 2008 Sep 20; 17(9):861-8. PubMed ID: 18504768
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
    Rigby AJ, Ma J, Stafford RS.
    Menopause; 2007 Sep 20; 14(5):853-8. PubMed ID: 17429334
    [Abstract] [Full Text] [Related]

  • 19. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C.
    J Endocrinol Invest; 2005 Sep 20; 28(10 Suppl):80-4. PubMed ID: 16550729
    [Abstract] [Full Text] [Related]

  • 20. Changes in the use of Hormone Replacement Therapy in New Zealand following the publication of the Women's Health Initiative trial.
    Bilgrami I, Blower K, Feng J, Stefanko G, Tan E.
    N Z Med J; 2004 Nov 26; 117(1206):U1175. PubMed ID: 15570344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.